Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
BioNTech SE
BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026
May 22, 2026
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
May 21, 2026
BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer
May 19, 2026
BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update
May 16, 2026
BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030
May 16, 2026
BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer
January 28, 2026